Clinical Trial Update: SAT vs Escitalopram for Rectal Hypersensitivity [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing SAT to escitalopram for rectal hypersensitivity in IBS-C; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Constipation
• Rectal Hypersensitivity

Drugs mentioned

• Escitalopram (escitalopram)
• SAT

Snippet

Sponsor: Augusta University | Conditions: Rectal Hypersensitivity, Irritable Bowel Syndrome-Constipation | Phase 2 | Status: COMPLETED